A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non-Small Cell Lung Cancer

類似資料

• Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
  著者:: Goldberg, Sarah B., 等
  出版事項: (2013)
• Reduced erlotinib sensitivity of EGFR mutant non-small cell lung cancer following cisplatin exposure: A cell culture model of second-line erlotinib treatment
  著者:: Chin, Tan Min, 等
  出版事項: (2008)
• Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib
  著者:: Nishino, Mizuki, 等
  出版事項: (2016)
• Role of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
  著者:: Mak, Raymond H., 等
  出版事項: (2011)
• Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer
  著者:: Heist, Rebecca S., 等
  出版事項: (2015)